– PERU, Lima – Auna S.A.A., one of the largest and most respected players in the Latin American healthcare industry today announced the appointment of Victor Serra as its new CEO, effective January 2, 2023, to succeed founding member Luis Felipe Pinillos who will be appointed Vice-Chairman of the Board of Directors.
“The Board would like to thank Luis Felipe for not only his considerable contributions to the development of Auna but also for his vision, passion, and dedication to transforming healthcare in Latin America. He led the expansion of the operation into new markets and new lines of service and successfully oversaw the transformational transactions that have positioned the Company as one of the largest healthcare groups in Latin America with strong prospects for the future,” said Board Chairman, Jesus Zamora. “We welcome Victor who brings a proven track record of leadership and innovation at scale in the healthcare industry and shares our mission to transform healthcare in Latin America, facilitating increased access, improved medical outcomes, and patient experiences. The entire Board is confident that Victor is the right person to serve as Auna’s next CEO, leading the consolidation of operations in the region and continuing to build upon our strong momentum.”
About Victor Serra
Mr. Serra is a proven and seasoned business leader who has operated at scale and within large global operations in various industries including a five-year tenure in healthcare. Most recently he was the CEO of Americas Medical Services, a business unit of the UnitedHealth Group in Brazil, where he led the development of specialties and excellence centers within a network of 23 hospitals operated by a workforce of over 35,000. Previously, Mr. Serra held various leadership roles in public and private multinational companies and private equity funds such as Wal-Mart, Carlyle, and Sara Lee, where he was a recipient of the Record Performance Award by Sara Lee Corp´s Chairman. He has also developed practices at distinguished family offices. He has held leadership roles globally, in countries including Mexico, the USA, Brazil, and Italy.
“I am honored and excited to join such a strong, respected organization that is transforming healthcare in Latin America. With a growing patient base, recent regional expansion, and an industry-leading executive team already in place, I’m looking forward to building on the successful trajectory set by Luis Felipe and the leadership team,” said Victor Serra. “I am passionate about patient journeys and striving to achieve the best quality of care within clinical centers of excellence. My motivation is to advance Auna´s mission at its hospital and membership ecosystem and to maximize the transformational power of its regional footprint.”
Victor holds an MBA from the UCLA Anderson School of Management, an Executive General Management degree from Harvard Business School, and has been a faculty member at the Wharton School of Business where he taught in Wharton´s Private Equity Executive Program.
About Auna
Founded in 1989, Auna is one of the largest and most respected companies in Latin America’s healthcare industry. The Company operates 16 hospitals and 10 healthcare centers at all levels of complexity in Mexico, Peru, and Colombia, and is the leading provider of oncology healthcare plans with a fully integrated model in Peru. Since 2018, Auna has expanded rapidly, not only through growth in its oncology segment and execution of organic developments but also through the acquisition of important healthcare players in the high-growth markets of Colombia and Mexico. Auna is backed by Enfoca, its controlling shareholder, and one of the leading investment firms in Latin America.
For more information: https://www.aunainvestors.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
